340-R2 Search Results


92
Bio-Techne corporation recombinant human activin riia fc chimera protein, cf
Recombinant Human Activin Riia Fc Chimera Protein, Cf, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/340-R2/bio-techne+corporation___340-r2-cf?v=Bio-Techne+corporation
Average 92 stars, based on 1 article reviews
recombinant human activin riia fc chimera protein, cf - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

93
R&D Systems actriib receptor ectodomain
FIGURE 3 Heparin inhibits BMP-7 GF but not BMP-7 CPLX interaction with <t>ActRIIB.</t> (A) BMP-7 GF or CPLX (20 nM) were preincubated with heparin in increasing concentrations (0–80 nM) before flown over the ActRIIB receptor <t>ectodomain</t> that was immobilized onto a CM5 chip. (B) (left) Percentage of binding signal for BMP-7 GF and CPLX to ActRIIB in the presence of increasing heparin concentrations. Data points represent averages obtained from three independent experiments. Error bars indicate ± SD. (right) Cartoon illustrates BMP-7 GF and CPLX interaction with ActRII in presence of heparin.
Actriib Receptor Ectodomain, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/340-R2/10__1096_slash_fj__202200904r-99-25-31?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
actriib receptor ectodomain - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

93
R&D Systems recombinant human actriib fc
FIGURE 3 Heparin inhibits BMP-7 GF but not BMP-7 CPLX interaction with <t>ActRIIB.</t> (A) BMP-7 GF or CPLX (20 nM) were preincubated with heparin in increasing concentrations (0–80 nM) before flown over the ActRIIB receptor <t>ectodomain</t> that was immobilized onto a CM5 chip. (B) (left) Percentage of binding signal for BMP-7 GF and CPLX to ActRIIB in the presence of increasing heparin concentrations. Data points represent averages obtained from three independent experiments. Error bars indicate ± SD. (right) Cartoon illustrates BMP-7 GF and CPLX interaction with ActRII in presence of heparin.
Recombinant Human Actriib Fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/340-R2/bio_rxiv__2023__09__25__559288-233-4-10?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
recombinant human actriib fc - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

92
R&D Systems recombinant human actriia fc
FIGURE 3 Heparin inhibits BMP-7 GF but not BMP-7 CPLX interaction with <t>ActRIIB.</t> (A) BMP-7 GF or CPLX (20 nM) were preincubated with heparin in increasing concentrations (0–80 nM) before flown over the ActRIIB receptor <t>ectodomain</t> that was immobilized onto a CM5 chip. (B) (left) Percentage of binding signal for BMP-7 GF and CPLX to ActRIIB in the presence of increasing heparin concentrations. Data points represent averages obtained from three independent experiments. Error bars indicate ± SD. (right) Cartoon illustrates BMP-7 GF and CPLX interaction with ActRII in presence of heparin.
Recombinant Human Actriia Fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/340-R2/10__1042_slash_bcj20230404-280-0-10?v=R%26D+Systems
Average 92 stars, based on 1 article reviews
recombinant human actriia fc - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

Image Search Results


FIGURE 3 Heparin inhibits BMP-7 GF but not BMP-7 CPLX interaction with ActRIIB. (A) BMP-7 GF or CPLX (20 nM) were preincubated with heparin in increasing concentrations (0–80 nM) before flown over the ActRIIB receptor ectodomain that was immobilized onto a CM5 chip. (B) (left) Percentage of binding signal for BMP-7 GF and CPLX to ActRIIB in the presence of increasing heparin concentrations. Data points represent averages obtained from three independent experiments. Error bars indicate ± SD. (right) Cartoon illustrates BMP-7 GF and CPLX interaction with ActRII in presence of heparin.

Journal: The FASEB Journal

Article Title: Targeting of bone morphogenetic protein complexes to heparin/heparan sulfate glycosaminoglycans in bioactive conformation

doi: 10.1096/fj.202200904r

Figure Lengend Snippet: FIGURE 3 Heparin inhibits BMP-7 GF but not BMP-7 CPLX interaction with ActRIIB. (A) BMP-7 GF or CPLX (20 nM) were preincubated with heparin in increasing concentrations (0–80 nM) before flown over the ActRIIB receptor ectodomain that was immobilized onto a CM5 chip. (B) (left) Percentage of binding signal for BMP-7 GF and CPLX to ActRIIB in the presence of increasing heparin concentrations. Data points represent averages obtained from three independent experiments. Error bars indicate ± SD. (right) Cartoon illustrates BMP-7 GF and CPLX interaction with ActRII in presence of heparin.

Article Snippet: Kinetic constants were calculated as described previously.41 For assessing how heparin binding to BMP- 7 GF and CPLX impacts the interaction with BMP receptors, the ActRIIB receptor ectodomain (#340- R2- 100/CF; R&D Systems) was immobilized as previously explained at 800 RUs to the CM5 chip surface.

Techniques: Binding Assay